Europe In-Vitro Diagnostics Market poised to reach USD 16.2 billion by 2022Posted by rohan on November 27th, 2017 According to the report In-Vitro Diagnostics Market, published by Market Data Forecast, the Europe market is projected to reach USD 16.2 billion by 2022 at a CAGR 5.10 % from 2017 to 2022. In Vitro Diagnostics refers to medical devices and accessories which are used to perform tests on samples taken from body. They help to detect diseases and infection. Some of these tests are reformed in laboratory while others can be used at home. In-Vitro Diagnostics Market: Drivers & Restraints Increasing geriatric population, rise in chronic diseases and growing lifestyle disorders like diabetes are the primary factors driving the growth of the market. Also advancements in technology and increasing clinical laboratories offering a range of advanced IVD testing services are also boosting this industry. However unclear reimbursement policies and high costs of healthcare are restraining the growth of the market. Get accurate market forecast and analysis on the In-Vitro Diagnostics Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/europe-in-vitro-diagnostics-market-148/request-sample In-Vitro Diagnostics Market: Segmentation ByProduct
By Technology
By Application
By Geography
o U.K o Spain o Germany o Italy o France In-Vitro Diagnostics Market: Overview In 2017, Reagents and Kits category in the product category had the largest market share. Also it is the fastest growing segment during the forecast period. In the end user category hospitals had the largest market share as tests are majorly performed in hospitals. In-Vitro Diagnostics Market: Key Players The in-vitro diagnostics market is highly competitive with a large number of players. Some of the major Companies are Abbott Laboratories, Johnson and Johnson, Siemens Healthcare, Becton Dickinson, Roche Diagnostics, and Beckman Coulter Inc. Other companies include Biomérieux, Ortho Clinical Diagnostics, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Sysmex Corporation and Thermo Fisher Scientific, Inc. About Market Data Forecast: Like it? Share it!More by this author |